Canakinumab for Treatment of Adult-onset Still's Disease
Clinical trial NCT02204293 · TERMINATED
Trial details
- NCT number
- NCT02204293
- Sponsor
- Charite University, Berlin, Germany
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-21
- Primary completion
- 2018-05-05
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.